20 related articles for article (PubMed ID: 38583233)
1. Effects of Maackia amurensis seed lectin (MASL) on oral squamous cell carcinoma (OSCC) gene expression and transcriptional signaling pathways.
Hamilton KL; Sheehan SA; Retzbach EP; Timmerman CA; Gianneschi GB; Tempera PJ; Balachandran P; Goldberg GS
J Cancer Res Clin Oncol; 2021 Feb; 147(2):445-457. PubMed ID: 33205348
[TBL] [Abstract][Full Text] [Related]
2. Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms.
Ochoa-Alvarez JA; Krishnan H; Pastorino JG; Nevel E; Kephart D; Lee JJ; Retzbach EP; Shen Y; Fatahzadeh M; Baredes S; Kalyoussef E; Honma M; Adelson ME; Kaneko MK; Kato Y; Young MA; Deluca-Rapone L; Shienbaum AJ; Yin K; Jensen LD; Goldberg GS
Oncotarget; 2015 Apr; 6(11):9045-60. PubMed ID: 25826087
[TBL] [Abstract][Full Text] [Related]
3. Plant lectin can target receptors containing sialic acid, exemplified by podoplanin, to inhibit transformed cell growth and migration.
Ochoa-Alvarez JA; Krishnan H; Shen Y; Acharya NK; Han M; McNulty DE; Hasegawa H; Hyodo T; Senga T; Geng JG; Kosciuk M; Shin SS; Goydos JS; Temiakov D; Nagele RG; Goldberg GS
PLoS One; 2012; 7(7):e41845. PubMed ID: 22844530
[TBL] [Abstract][Full Text] [Related]
4. Evidence that Maackia amurensis seed lectin (MASL) exerts pleiotropic actions on oral squamous cells with potential to inhibit SARS-CoV-2 infection and COVID-19 disease progression.
Sheehan SA; Hamilton KL; Retzbach EP; Balachandran P; Krishnan H; Leone P; Lopez-Gonzalez M; Suryavanshi S; Kumar P; Russo R; Goldberg GS
Exp Cell Res; 2021 Jun; 403(1):112594. PubMed ID: 33823179
[TBL] [Abstract][Full Text] [Related]
5. Maackia amurensis seed lectin (MASL) ameliorates articular cartilage destruction and increases movement velocity of mice with TNFα induced rheumatoid arthritis.
Hamilton KL; Greenspan AA; Shienbaum AJ; Fischer BD; Bottaro A; Goldberg GS
Biochem Biophys Rep; 2022 Dec; 32():101341. PubMed ID: 36120492
[TBL] [Abstract][Full Text] [Related]
6. Glycobiology of head and neck squamous epithelia and carcinomas.
Plzák J; Smetana K; Chovanec M; Betka J
ORL J Otorhinolaryngol Relat Spec; 2005; 67(2):61-9. PubMed ID: 15821350
[TBL] [Abstract][Full Text] [Related]
7. Maackia amurensis seed lectin (MASL) and soluble human podoplanin (shPDPN) sequence analysis and effects on human oral squamous cell carcinoma (OSCC) cell migration and viability.
Yin AC; Holdcraft CJ; Brace EJ; Hellmig TJ; Basu S; Parikh S; Jachimowska K; Kalyoussef E; Roden D; Baredes S; Capitle EM; Suster DI; Shienbaum AJ; Zhao C; Zheng H; Balcaen K; Devos S; Haustraete J; Fatahzadeh M; Goldberg GS
Biochem Biophys Res Commun; 2024 May; 710():149881. PubMed ID: 38583233
[TBL] [Abstract][Full Text] [Related]
8. Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral Cancer Treatment.
Hwang BO; Park SY; Cho ES; Zhang X; Lee SK; Ahn HJ; Chun KS; Chung WY; Song NY
Front Immunol; 2021; 12():807600. PubMed ID: 34987523
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and clinicopathological significance of podoplanin immunoexpression in oral and oropharyngeal squamous cell carcinoma: A systematic review.
Mello FW; Kammer PV; Silva CAB; Parkinson EK; Monteiro L; Warnakulasuriya S; Rivero ERC
J Oral Pathol Med; 2021 Jan; 50(1):1-9. PubMed ID: 32449167
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
